
Winter 2025
By Ross Perry
ALK Positive has gifted a generous grant to support Dana-Farber Cancer Institute’s Alice Shaw, MD, PhD’s, pioneering research on methylthioadenosine phosphorylase loss in ALK-positive lung cancer. This vital funding will drive innovative strategies to improve patient outcomes, empowering breakthroughs that enhance care for individuals affected by ALK-positive lung cancer worldwide.
